ZIG
PRAX icon

Zuckerman Investment Group’s Praxis Precision Medicines PRAX Stock Holding History

Zuckerman Investment Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-699
Closed -$17.9K – 140
2023
Q3 		$17.9K Hold
699
– – ﹤0.01% 129
2023
Q2 		$12.1K Hold
699
– – ﹤0.01% 123
2023
Q1 		$8.48K Hold
699
– – ﹤0.01% 122
2022
Q4 		$24.9K Hold
699
– – ﹤0.01% 127
2022
Q3 		$24K Hold
699
– – ﹤0.01% 115
2022
Q2 		$26K Hold
699
– – ﹤0.01% 112
2022
Q1 		$107K Hold
699
– – 0.02% 108
2021
Q4 		$206K Hold
699
– – 0.03% 110
2021
Q3 		$194K Buy
+699
New +$190K 0.03% 109

Other funds holding PRAX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Zuckerman Investment Group's PRAX Position: Q4 2023 in Review

Zuckerman Investment Group sold out of Praxis Precision Medicines (PRAX) in Q4 2023, closing a stake of 699 shares — an estimated $17.9K sold.

Zuckerman Investment Group first reported a position in PRAX in Q3 2021 and held it in 9 quarters. The position peaked at $206K in Q4 2021. 60 funds tracked by Wall St. Rank hold PRAX as of Q4 2023.

  • Zuckerman Investment Group reported no remaining Praxis Precision Medicines position as of Q4 2023 after selling out during the quarter.
  • Zuckerman Investment Group sold 699 Praxis Precision Medicines shares in Q4 2023, an estimated $17.9K.
  • Zuckerman Investment Group first reported a position in Praxis Precision Medicines in Q3 2021 and held it in 9 quarters.
  • Zuckerman Investment Group's Praxis Precision Medicines position peaked at $206K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2023.

Based on Zuckerman Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.